Children with Sickle Cell Disease in Northern Benin: Follow up of a Cohort at the Borgou/Alibori Branch of Integrated Medical Healthcare Center for Infants and Pregnant Women with Sickle Cell Disease from 2017 to 2022
Introduction: Sickle cell disease is a public health problem in sub-Saharan Africa. A national referral center for the management of infants and pregnant women with sickle cell disease (CPMI-NFED) was created three decades ago in Cotonou, in the south of Benin with two regional branches including that of Parakou in the North for better access of patients to specialized care. This work is a review of five years of activities in order to describe the epidemiological, clinical, hematological and evolutionary profiles of the children followed up in the said branch. Method: This was a descriptive and retrospective cross-sectional study on the medical records of children with sickle cell disease, followed up at the regional branch of CPMI-NFED in Borgou/Alibori from June 1, 2017 to May 31, 2022. The variables studied were epidemiological, clinical, biological and evolutionary. Results: A total of 101 children with sickle cell disease were included in the study, including 78 homozygous SS (77.2%) and 23 heterozygous SC (22.8%). Their mean age at inclusion was 51.2 ± 37.6 months [6 - 204]. The sex ratio was 1.4. Vaso-occlusive crises were the main diagnostic circumstances in 42.3% of homozygotes. More than half of the children (51.5%) had a regular follow-up. The average baseline level of hemoglobin (Hb) in homozygous children was 8.8 ± 1.4 g/dl [5.8 - 11.5]; and the rate of Hb S varied between 61.9 and 94.7%. In heterozygous SC children, the mean baseline level of Hb was 10.7 ± 0.6 g/dl [9.7 - 11.5]. Acute complications observed during follow-up were dominated by pneumonia and vaso-occlusive crises in both phenotypes. The overall mortality was 3% and only affected homozygous patients. Conclusion: On average, three out of four children were homozygous in our cohort. The main acute complications were infectious and vaso-occlusive. The mortality only affected homozygous carriers. Specialized follow-up has contributed to improving the quality of life of children with sickle cell disease. This could be implemented on a large scale for better survival of children with sickle cell disease.
References
[1]
Ugwu, N.I. (2016) Sickle Cell Disease: Awareness, Knowledge and Attitude among Undergraduate Students of a Nigerian Tertiary Educational Institution. Asian Journal of Medical Sciences, 7, 87-92. https://doi.org/10.3126/ajms.v7i5.15044
[2]
Piel, F.B., Hay, S.I., Gupta, S., Weatherall, D.J. and Williams, T.N. (2013) Global Burden of Sickle Cell Anemia in Children under Five, 2010-2050: Modeling Based on Demographics, Excess Mortality, and Interventions. PLOS Medicine, 10, e1001484. https://doi.org/10.1371/journal.pmed.1001484
[3]
Rees, D.C., Williams, T.N. and Gladwin, M.T. (2010) Sickle-Cell Disease. The Lancet, 376, 2018-2031. https://doi.org/10.1016/S0140-6736(10)61029-X
[4]
Adegoke, S.A., Abioye-Kuteyi, E.A. and Orji, E.O. (2014) The Rate and Cost of Hospitalization in Children with Sickle Cell Anaemia and Its Implications in a Developing Economy. African Health Sciences, 14, 475-480. https://doi.org/10.4314/ahs.v14i2.27
[5]
Adigwe, O.P., Onoja, S.O. and Onavbavba, G. (2023) A Critical Review of Sickle Cell Disease Burden and Challenges in Sub-Saharan Africa. Journal of Blood Medicine, 14, 367-376. https://doi.org/10.2147/JBM.S406196
[6]
McGann, P.T. (2016) Time to Invest in Sickle Cell Anemia as a Global Health Priority. Pediatrics, 137, e20160348. https://doi.org/10.1542/peds.2016-0348
[7]
Grosse, S.D., Odame, I., Atrash, H.K., et al. (2011) Sickle Cell Disease in Africa. American Journal of Preventive Medicine, 41, S398-S405. https://doi.org/10.1016/j.amepre.2011.09.013
[8]
République du Bénin Ministère de la Santé (2019) Programme national de lutte contre les maladies non transmissibles : Plan stratégique intégré de lutte contre les maladies non transmissibles 2019-2023.
[9]
Zohoun, A., Baglo Agbodande, T., Zohoun, L. and Anani, L. (2020) Prevalence of Hemoglobin Abnormalities in an Apparently Healthy Population in Benin. Hematology, Transfusion and Cell Therapy, 42, 145-149. https://doi.org/10.1016/j.htct.2019.06.005
[10]
Présidence de la république du Bénin (2010) Décret N° 2010-263 du 11Juin 2010 portant création, attribution, organisation et fonctionnement du Centre de prise en charge médicale intégrée du nourrisson et de la femme enceinte atteints de drépanocytose (CPMI-NFED).
[11]
Diagne, I., Ndiaye, O., Moreira, C., Signate-Sy, H., Camara, B., Diouf, S., et al. (2000) Les syndromes drépanocytaires majeurs en pédiatrie a Dakar (Senegal). Archives de Pédiatrie, 7, 16-24. https://doi.org/10.1016/S0929-693X(00)88912-5
[12]
Nacoulma, E.W., Sakande, J., Kafando, E., Kpowbié, E.D. and Guissou, I.P. (2006) Profil hématologique et biochimique des drépanocytaires SS et SC en phase stationnaire au Centre Hospitalier National Yalgado Ouedraogo de Ouagadougou. Mali Medical, 21, 8-11.
[13]
Shongo, M.Y.P., Mukuku, O., Lubala, T.K., Mutombo, A.M., Kanteng, G.W., Umumbu, W.S., et al. (2014) Drépanocytose chez l’enfant lushois de 6 à 59 mois en phase stationnaire: Epidémiologie et clinique. The Pan African Medical Journal, 19, Article 71. https://doi.org/10.11604/pamj.2014.19.71.3684
[14]
Rahimy, M.C., Gangbo, A., Ahouignan, G., Adjou, R., Deguenon, C., Goussanou, S., et al. (2003) Effect of a Comprehensive Clinical Care Program on Disease Course in Severely Ill Children with Sickle Cell Anemia in a Sub-Saharan African Setting. Blood, 102, 834-838. https://doi.org/10.1182/blood-2002-05-1453
[15]
Bianga, V.F., Nangunia, M., Oponjo, F.M., Itongwa, J.M., Mushubusha, J.I., Colombe, M.M., et al. (2022) Clinical Profile of Sickle Cell Disease in Children Treated at “Cliniques Universitaires de Bukavu” and “Clinique Ami des Enfants”, Bukavu, Democratic Republic of the Congo. The Pan African Medical Journal, 41, Article 97. https://doi.org/10.11604/pamj.2022.41.97.29629
[16]
Thiam, L., Dramé, A., Coly, I.Z., Diouf, F.N., Seck, N., Boiro, D., et al. (2017) Profils épidémiologiques, cliniques et hématologiques de la drépanocytose homozygote SS en phase intercritique chez l’enfant à Ziguinchor, Sénégal. Revue d’Oncologie Hématologie Pédiatrique, 5, 130-135. https://doi.org/10.1016/j.oncohp.2017.10.003
[17]
Ruhanga, M. and Mashako, Y.K. (2019) Profil épidémiologique et clinique de la drépanocytose à l’hôpital provincial du Nord-Kivu. La Revue Malgache de Pédiatrie,2, 62-69.
[18]
Beuzard, Y. and Galactero, S. (1992) Drépanocytose. In: Dreyfus, et al., Eds., Hématologie (3e Edition), Flammarion, Paris, 378-392.
[19]
Damien, B.G., Sode, A.I., Bocossa, D., Elanga-Ndille, E., Aguemon, B., Corbel, V., et al. (2022) Bayesian Spatial Modelling of Malaria Burden in Two Contrasted Eco-Epidemiological Facies in Benin (West Africa): Call for Localized Interventions. BMC Public Health, 22, Article No. 1754. https://doi.org/10.1186/s12889-022-14032-9
[20]
Islam, M.R., Moinuddin, M., Ayeda Ahmed, A. and Syed, M.S. (2021) Association of Sickle Cell Disease with Anthropometric Indices among Under-Five Children: Evidence from 2018 Nigeria Demographic and Health Survey. BMC Medicine, 19, Article No. 5. https://doi.org/10.1186/s12916-020-01879-1
[21]
Hyacinth, H.I., Adekeye, O.A. and Yilgwan, C.S. (2013) Malnutrition in Sickle Cell Anemia: Implications for Infection, Growth, and Maturation. Journal of Social, Behavioral, and Health Sciences, 7, 1-11.
[22]
Borel, M.J., Buchowski, M.S., Turner, E.A., Peeler, B.B., Goldstein, R.E. and Flakoll, P.J. (1998) Alterations in Basal Nutrient Metabolism Increase Resting Energy Expenditure in Sickle Cell Disease. American Journal of Physiology-Endocrinology and Metabolism, 274, E357-E364. https://doi.org/10.1152/ajpendo.1998.274.2.E357
[23]
Mandese, V., Bigi, E., Bruzzi, P., Palazzi, G., Predieri, B., Lucaccioni, L., et al. (2019) Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study. BMC Pediatrics, 19, Article No. 56. https://doi.org/10.1186/s12887-019-1423-9
[24]
Bégué, P. and Castello-Herbreteau, B. (2001) La drépanocytose : De l’enfant à l’adolescent. Prise en charge en 2001. Bulletin de la Société de pathologie exotique, 94, 85-89.
[25]
Adeodu, O.O., Akinlosotu, M.A., Adegoke, S.A. and Oseni, S.B.A. (2017) Foetal Haemoglobin and Disease Severity in Nigerian Children with Sickle Cell Anaemia. Mediterranean Journal of Hematology and Infectious Diseases, 9, e2017063. https://doi.org/10.4084/mjhid.2017.063
[26]
Paulo, V., Rezendea, M.V., Santosa, G.F., Camposa, L.L.M., et al. (2018) Clinical and Hematological Profile in a Newborn Cohort with Hemoglobin SC. Jornal de Pediatria, 94, 666-672. https://doi.org/10.1016/j.jped.2017.09.010
[27]
Brousse, V., Buffet, P. and Rees, D. (2014) Thespleen and Sickle Cell Disease: The Sick (led)Spleen. British Journal of Haematology, 166, 165-176. https://doi.org/10.1111/bjh.12950
[28]
Makani, J., Williams, T.N. and Marsh, K. (2007) Sickle Cell Disease in Africa: Burden and Research Priorities. Annals of Tropical Medicine & Parasitology, 101, 3-14. https://doi.org/10.1179/136485907X154638
[29]
Marks, L.J., Munube, D., Kasirye, P., Mupere, E., Jin, Z., LaRussa, P., et al. (2018) Stroke Prevalence in Children with Sickle Cell Disease in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Global Pediatric Health, 5, 1-9. https://doi.org/10.1177/2333794X18774970
[30]
Ladu, A.I., Aiyenigba, A.O., Adekile, A. and Bates, I. (2021) The Spectrum of Splenic Complications in Patients with Sickle Cell Disease in Africa: A Systematic Review. British Journal of Haematology, 193, 26-42. https://doi.org/10.1111/bjh.17179
[31]
Serjeant, G.R., Ashcroft, M.T. and Serjeant, B.E. (1973) The Clinical Features of Haemoglobin SC Disease in Jamaica. British Journal of Haematology, 24, 491-501. https://doi.org/10.1111/j.1365-2141.1973.tb01675.x
